Notebook

NEW AND IMPROVED: Hoechst Merion Roussel's new research facility (inset) in Bridgewater, N.J. will house activities in biotechnology, automated screening and robotics, computational and medicinal chemistry, molecular modeling, and biophysics. Automated high throughput screening (above) will allow researchers to search huge chemical libraries for promising therapeutic compounds. OPENING DAY AT HOECHST Hoechst Marion Roussel (HMR) Inc., based in Frankfurt, Germany, marked the beginning of a new

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

COMMON COLD: A view of the common cold virus, which has 60 sites capable of connecting to ICAM-1 receptors, is depicted in the computer-simulated model. ICAM, THEY SAW Knowing your way around the battlefield is a necessary first step on the road to victory. Just ask researchers at Purdue University. A team of investigators led by Michael G. Rossmann, a professor of biological sciences at Purdue, have successfully mapped in atomic detail the three-dimensional structure of the intercellular adhesion molecule-1 (ICAM-1), a receptor cell that binds to rhinovirus, the most common cause of the common cold (J. Bella et al., Proceedings of the National Academy of Sciences, 95:4140-45, 1998). Through an understanding of the structure of ICAM-1, scientists hope to discover precisely how the virus enters cells and causes infection, according to Jordi Bella, a postdoctoral researcher at Purdue and lead author of the study. "Right now, we only know ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies